| Literature DB >> 30866928 |
Edilu Jorga Sarba1, Kebede Abdisa Kelbesa2, Morka Dandecha Bayu3, Endrias Zewdu Gebremedhin2, Bizunesh Mideksa Borena2, Ayichew Teshale4.
Abstract
BACKGROUND: Escherichia coli is bacteria that exist as commensal in the intestine of animals and humans, but pathogenic strains cause disease in chickens. The development of antimicrobial resistance in E. coli is one of major concern worldwide. A cross-sectional study was conducted from November, 2015 to April, 2016 in and around Ambo town on backyard chicken with the objectives of isolating E. coli from selected visceral organs, assessment of potential risk factor and determination of antimicrobial resistance pattern of the isolates.Entities:
Keywords: Ambo; Antimicrobial resistance; Chicken; E. coli; Visceral organ
Mesh:
Substances:
Year: 2019 PMID: 30866928 PMCID: PMC6417126 DOI: 10.1186/s12917-019-1830-z
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Logistic regression analyses of the risk factors for isolation of E. coli in chicken
| Risk factor | Category | No. Examined | No. Positive (%) | Univariable | Multivariable | ||
|---|---|---|---|---|---|---|---|
| OR (95% CI) | P. value | OR (95% CI) | P. value | ||||
| Breed | Exotic | 28 | 8 (28.6) | 1.0 | – | – | |
| Local | 163 | 54 (33.1) | 1.23 (0.51–2.99) | 0.0635 | |||
| Age | Young | 72 | 17 (23.6) | 1.0 | 1.0 | ||
| Adult | 119 | 45 (37.8) | 1.96 (1.02–3.79) | 0.044 | 2.5 (1.22–5.11) | 0.012 | |
| Sex | Male | 70 | 22 (31.4) | ||||
| Female | 121 | 40 (33.1) | 0.92 (0.49–1.74) | 0.817 | – | – | |
| Season | Dry | 83 | 23 (27.7) | 1.0 | |||
| Wet | 108 | 39 (36.1) | 0.68 (0.36–1.26) | 0.220 | 0.74 (0.27–1.97) | 0.550 | |
| District | Guder & Ijaji | 55 | 14 (25.5) | 1.0 | 1.0 | ||
| Dire inchicni | 40 | 11 (27.5) | 1.11 (0.44–2.79) | 0.823 | 2.1 (0.67–6.49) | 0.200 | |
| Ambo | 64 | 23 (35.9) | 1.19 (0.74–3.63) | 0.220 | 0.57 (0.43–3.27) | 0.724 | |
| Holeta | 32 | 14 (43.75) | 2.28 (0.90–5.75) | 0.081 | 2.22 (0.83–5.90) | 0.110 | |
| Health status | Healthy | 95 | 22 (22.1) | 1.0 | – | ||
| Sick | 96 | 40 (42.7) | 2.44 (1.31–4.57) | 0.005 | 3.28 (1.54–6.96) | 0.002 | |
| Diarrhoea | Absent | 113 | 29 (25.7) | 1.0 | |||
| 78 | 33 (41.3) | 2.12 (1.15–3.93) | 0.017 | ||||
Antimicrobial resistance pattern of E. coli isolates from chicken visceral organs
| Antimicrobial class | Antimicrobial discs and concentration | |||
|---|---|---|---|---|
| No susceptible (%) | No Intermediate (%) | No Resistant (%) | ||
| Aminoglycosides | Streptomycin (10 μg) | 70 (85) | 12 (15) | 0 (0) |
| Kanamycin (30 μg) | 62 (75) | 12 (15) | 8 (10) | |
| Gentamicin (30 μg) | 73 (89) | 9 (11) | 0 (0) | |
| Amikacin (30 μg) | 57 (69.6) | 19 (23.1) | 6 (7.3) | |
| β-lactams | Amoxicillin (20 μg) | 0 (0) | 0 (0) | 82 (100) |
| Cloxcillin (5 μg) | 0 (0) | 0 (0) | 82 (100) | |
| Cephems | Cefuroxime (30 μg) | 0 (0) | 0 (0) | 82 (100) |
| Ceftazidime (30 μg) | 69 (84.6) | 0 (0) | 13 (15.4) | |
| Cefotaxime (30 μg) | 0 (0) | 6 (7.3) | 76 (92.7) | |
| Phenicols | Chloramphenicol (30 μg) | 52 (63.4) | 16 (19.5) | 14 (17.1) |
| Quinolones | Ciprofloxacin (5 μg) | 82 (100) | 0 (0) | 0 (0) |
| Nalidxic acid (30 μg) | 68 (83) | 8 (9.7) | 6 (7.3) | |
| Nitrofurans | Nitrofurantoin (10 μg) | 63 (76.8) | 1 (1.2) | 18 (23.2) |
| Tetracyclines | Tetracycline (30 μg) | 44 (53.7) | 0 (0) | 38 (46.3) |
| Folate pathway inhibitors | Sulfamethoxazole-trimethoprim (1.25/23.75 μg) | 82 (100) | 0 (0) | 0 (0) |
| Fluoroquinolones | Norfloxacin (10 μg) | 82 (100) | 0 (0) | 0 (0) |
Multidrug resistance patterns in E. coli isolated from chicken visceral organs
| Number | Antimicrobial resistance pattern | No. of resistant isolates (%) |
|---|---|---|
| Two | AMX CRX | 34 (41.5) |
| Four | AMX CRX CHL | 10 (12.2) |
| Four | AMX CRX TET | 20 (24.4) |
| Five | AMX CRX TET NIT | 8 (9.8) |
| Seven | AMX CRX TET NIT KN NLD | 6 (7.3) |
| Seven | AMX CRX TET NIT KN CHL | 4 (4.9) |
AMX-Amoxicillin (β-lactams), CRX-Cefuroxime (Cephems), TET-Tetracycline, CHL- Chloramphinicol (Phenicols), NIT-Nitrofurantoin, KN-Kanaycin (Aminoglcosides), NLD- Nalidxic acid (Quinolones)